在中度至重度斑块性牛皮患者的实验室监测
Jonathan M Fenkel1, John A Osborne2, April W Armstrong3
1Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
The Journal of dermatological treatment
|December 5, 2025
概括
皮肤科医生可以通过与其他专家合作,有效监测接受生物或小分子治疗的斑块性牛皮患者. 这确保了安全和有益的治疗,有效地管理潜在的风险和并发症.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 斑块性牛皮是一种普遍的免疫媒介疾病,通常与诸如心血管疾病,糖尿病和情绪障碍等重大并发症有关.
- 虽然生物和小分子疗法为成年人中度至重度的斑块性牛皮提供了有效的治疗方法,但对于最佳的实验室监测存在不确定性,特别是对于伴随疾病的患者.
研究的目的:
- 为接受生物和小分子治疗的斑块性牛皮的成年患者进行实验室监测提供专家建议.
- 解决皮肤科医生对这些先进疗法的适当实验室监测的不确定性,特别是在伴随性疾病的背景下.
主要方法:
- 对用于斑块性牛皮的生物和小分子疗法的处方信息的审查.
- 结合来自现实世界的临床经验的专家建议.
- 包括一般实验室监测指南,用于牛皮患者常见的并发症.
主要成果:
- 个性化实验室监测对于优化生物和小分子疗法的风险效益概况至关重要.
- 建议侧重于对这些先进疗法的特定监测,承认对其他药物类别的潜在需求.
- 伴随性疾病的监测应根据个体患者的特征和医生的判断量身定制.
结论:
- 通过协作护理模式,可以通过先进疗法对斑块性牛皮患者进行有效的临床管理.
- 皮肤科医生,初级保健医生和专家之间的持续合作促进了全面的患者监测.
- 这种协作方法支持最大限度地提高治疗效益,同时最大限度地降低与斑块性牛皮治疗相关的风险.
相关概念视频
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
164
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
164
01:29Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
01:16Therapeutic Drug Monitoring: Overview and Classification
275
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
275
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
326
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
326
01:26Peripheral Artery Disease IV: Nursing Management
321
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
321